The Emisphere Advantage Investment Thesis
- Technology platform applicable across a diverse group of proteins, carbohydrates and other molecules
- Limited risk
- New oral mechanism for proven drugs
- Established leading partnerships
- Leveraging different programs for large, unmet patient populations
- Product candidates address a broad range of therapeutic areas
- Low cost, easy-to-scale technology
- Operating strategy in line with current cash position